| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ARVN | Common Stock | Options Exercise | $240,000 | +15,000 | +9.3% | $16.00 | 176,447 | 11 Mar 2022 | Direct | F1 |
| transaction | ARVN | Common Stock | Sale | $1,050,000 | -15,000 | -8.5% | $70.00 | 161,447 | 11 Mar 2022 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ARVN | Stock Option (right to buy) | Options Exercise | $240,000 | -15,000 | -47% | $16.00 | 16,710 | 11 Mar 2022 | Common Stock | 15,000 | $16.00 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2021. |
| F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2021. |
| F3 | This option award was granted on September 26, 2018, and the shares underlying the award were fully vested upon grant. |